Results 81 to 90 of about 613,500 (197)

Reducing the dose delivered to major intracranial blood vessels in brain radiotherapy using spot‐scanning proton arc therapy

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 9, September 2026.
Abstract Background Glioblastoma (GBM) patients have poor clinical prognoses, which may partially be explainable by correlations between radiation‐induced killing of circulating blood cells (CBCs) and worse clinical outcomes. Proton radiotherapy is currently delivered via intensity‐modulated proton therapy (IMPT), for which the target is irradiated ...
Peilin Liu   +5 more
wiley   +1 more source

Giant infiltrative cavernous malformation: Clinical presentation, intervention, and genetic analysis: Case report

open access: yes, 2004
OBJECTIVE AND IMPORTANCE: Cavernous malformations can present in children with a sporadic course of repeated hemorrhage and enlargement, but they are rarely aggressive, infiltrative, or multilobar.
Lawton, Michael T.   +5 more
core   +1 more source

Are cavernous sinus hemangiomas and cavernous malformations different entities?

open access: yes, 2006
Cavernous hemangiomas that occur within the cavernous sinus (CS) are different from cerebral cavernous malformations (CMs) clinically, on imaging studies, and in their response to treatment.
Lekovic, Gregory P   +5 more
core   +3 more sources

Multiscale Circuit Architecture Associated With Memory Dysfunction in Temporal Lobe Epilepsy

open access: yesAdvanced Science, Volume 13, Issue 53, 24 September 2026.
A multiscale precision‐mapping framework reveals that memory impairment in temporal lobe epilepsy arises from the convergence of focal medial temporal pathology, strategic white matter disconnection, and limbic‐centered metabolic network dysfunction.
Jiajie Mo   +12 more
wiley   +1 more source

Cerebral Cavernous Malformations [PDF]

open access: yesCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2000
I, Fleetwood, W, Hu, M, Hudon
openaire   +2 more sources

A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous Malformation

open access: yesFrontiers in Neurology, 2018
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by the presence of renal cysts and specific extrarenal abnormalities.
Christian Thomas   +7 more
doaj   +1 more source

Giant cavernous malformation in the child: Case presentation [PDF]

open access: yes, 2012
Cerebral cavernous malformations (CCMs) are rare lesions that occurs 5 to 13% of all intracranial vascular malformations, develop in 0.02-0.13% of the population. Extra axial cavernous Malformations are even more rare and estimated to be 0.4 to 2% of all
Shrestha, Rajendra   +2 more
core   +1 more source

Interrogating the ccm-3 Gene Network

open access: yesCell Reports, 2018
Summary: Cerebral cavernous malformations (CCMs) are neurovascular lesions caused by mutations in one of three genes (CCM1–3). Loss of CCM3 causes the poorest prognosis, and little is known about how it regulates vascular integrity. The C.
Benjamin Lant   +9 more
doaj   +1 more source

Neoplastic growth of cerebral cavernous malformation presenting with impending cerebral herniation: A case report and review of the literature on de novo growth of cavernomas [PDF]

open access: yes, 2001
Background: Cerebral cavernomas are rare vascular anomalies and their expansile growth has been considered to be mainly due to recurrent hemorrhages.
Siddiqui, Arshad A, Jooma, Rashid
core  

Familial cerebral cavernous malformation.

open access: yes, 2012
Cavernous malformations (CMs) occur in approximately 0.5% of the general population and represent 5-10% of the central nervous system vascular malformations. The majority of CMs appear sporadically but genetically determined familial forms account for 10%
Ziora Jakutowicz K   +5 more
core  

Home - About - Disclaimer - Privacy